The Benefit of Benralizumab Monoclonal Antibody Treatment for Severe Eosinophilic Asthma in a Case Series (Pulmonology Clinic Târgu Mureș, Romania)
, , , , , , e
14 ott 2021
INFORMAZIONI SU QUESTO ARTICOLO
Pubblicato online: 14 ott 2021
Pagine: 157 - 161
Ricevuto: 04 set 2021
Accettato: 11 set 2021
DOI: https://doi.org/10.2478/jim-2021-0030
Parole chiave
© 2021 Nimród László et al., published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.
László, Nimród
Clinic of Pneumology, Emergency County Clinical HospitalTârgu Mureș, Romania
Sárközy, Hédy Katalin
“George Emil Palade” University of Medicine, Pharmacy, Science and TechnologyTârgu Mureș, Romania
Man, Cristina Alexandra
Clinic of Pneumology, Emergency County Clinical HospitalTârgu Mureș, Romania
Ianoși, Edith Simona
“George Emil Palade” University of Medicine, Pharmacy, Science and TechnologyTârgu Mureș, Romania
Mátyás, Botond
“George Emil Palade” University of Medicine, Pharmacy, Science and TechnologyTârgu Mureș, Romania
Ciurba, Bianca Emilia
Clinic of Pneumology, Emergency County Clinical HospitalTârgu Mureș, Romania
Mărginean, Corina
Clinic of Pneumology, Emergency County Clinical HospitalTârgu Mureș, Romania
Jimborean, Gabriela
“George Emil Palade” University of Medicine, Pharmacy, Science and TechnologyTârgu Mureș, Romania